Tracey Vetterick

Tracey Vetterick joined Akebia in April 2021 as Vice President and Program Executive for vadadustat. Prior to joining Akebia, Tracey was VP, Chief Operating Officer for Oncology R&D at AstraZeneca with responsibilities including strategy and integration of the Oncology R&D organization, as well as managing site operations for AZ’s US R&D locations. From 2011 to 2019 Tracey served in several key roles at AZ including Head of Global Marketing for Immuno-Oncology, as well as roles in early asset commercial strategy, portfolio strategy and business development. Prior to joining AZ, Tracey spent 10 years at Genzyme Corporation, now Sanofi, in a number of roles focusing on renal disease, including business development, program management, European commercial operations and global marketing. Tracey has a B.A. in Zoology from Miami University (OH), and a M.S. in Biotechnology from Northwestern University.